...
首页> 外文期刊>Radiation oncology >In vivo surface dose measurement using GafChromic film dosimetry in breast cancer radiotherapy: comparison of 7-field IMRT, tangential IMRT and tangential 3D-CRT
【24h】

In vivo surface dose measurement using GafChromic film dosimetry in breast cancer radiotherapy: comparison of 7-field IMRT, tangential IMRT and tangential 3D-CRT

机译:在乳腺癌放射治疗中使用GafChromic膜剂量法进行体内表面剂量测量:7场IMRT,切向IMRT和切向3D-CRT的比较

获取原文
           

摘要

Purpose The purpose of this study was to compare the surface dose of 7-field IMRT (7?F-IMRT), tangential beam IMRT (TB-IMRT), and tangential beam 3D-CRT (3D-CRT) of breast cancer patients receiving adjuvant radiotherapy by means of in vivo GafChromic film dosimetry. Material and methods Breast cancer patients receiving adjuvant radiotherapy of the whole breast or the chest wall were eligible for the study. Study patients were treated with a treatment plan using two different radiotherapy techniques (first patient series, 3D-CRT followed by TB-IMRT; second patient series, TB-IMRT followed by 7?F-IMRT). The surface dose was evaluated on three consecutive treatment fractions per radiotherapy technique using in vivo GafChromic film dosimetry. The paired t-test was used to assess the difference of in vivo GafChromic film readings or calculated plan parameters of the compared pairs of radiation techniques for statistical significance. Results Forty-five unselected breast cancer patients were analysed in this study. 7?F-IMRT significantly reduced the surface dose compared to TB-IMRT. Differences were greatest in the central and lateral breast or chest wall region and amounted to a dose reduction of -11.8% to -18.8%. No significant difference of the surface dose was observed between TB-IMRT and 3D-CRT. A corresponding observation was obtained for the calculated skin dose derived from dose-volume histograms. Conclusions In adjuvant breast cancer radiotherapy, 7?F-IMRT offers a significantly reduced surface dose compared to TB-IMRT or 3D-CRT.
机译:目的本研究的目的是比较接受乳腺癌治疗的7场IMRT(7?F-IMRT),切线束IMRT(TB-IMRT)和切线束3D-CRT(3D-CRT)的表面剂量体内GafChromic膜剂量测定法进行辅助放疗。材料和方法接受全乳房或胸壁辅助放疗的乳腺癌患者符合研究条件。使用两种不同的放疗技术(第一个患者系列为3D-CRT,然后是TB-IMRT;第二个患者系列为TB-IMRT,然后是7?F-IMRT),按照治疗计划对研究患者进行治疗。使用体内GafChromic膜剂量测定法,对每种放疗技术的三个连续治疗级分评估表面剂量。配对t检验用于评估体内GafChromic胶片读数的差异或所比较的放射技术对的计算计划参数之间的统计学差异。结果本研究分析了45例未选择的乳腺癌患者。与TB-IMRT相比,7?F-IMRT显着降低了表面剂量。中央和外侧乳腺或胸壁区域的差异最大,剂量减少了-11.8%至-18.8%。在TB-IMRT和3D-CRT之间未观察到表面剂量的显着差异。对于从剂量-体积直方图得出的计算出的皮肤剂量,获得了相应的观察结果。结论在辅助乳腺癌放疗中,与TB-IMRT或3D-CRT相比,7?F-IMRT的表面剂量明显减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号